Dose-Response Relationship, DrugDrug Administration ScheduleRadiation InjuriesRadiation DosageRadiation, IonizingDose-Response Relationship, RadiationRadiation ToleranceRadiotherapyRadiotherapy DosageRadiationAntineoplastic AgentsCombined Modality TherapyRadiation OncologyRadiation ProtectionRadiation MonitoringRadiotherapy, ConformalRadiotherapy, Intensity-ModulatedDose FractionationRadiotherapy Planning, Computer-AssistedRadiotherapy, AdjuvantRadiation PneumonitisNeoplasmsRadiometryBrachytherapyNeoplasms, Radiation-InducedRadiation-Sensitizing AgentsCell Line, TumorRadiation Injuries, ExperimentalRadiosurgeryGamma RaysTreatment OutcomeCosmic RadiationDrug Screening Assays, AntitumorRadiotherapy, Computer-AssistedBrain NeoplasmsCisplatinDoxorubicinCranial IrradiationRadiotherapy, Image-GuidedParticle AcceleratorsNeoplasm Recurrence, LocalApoptosisRadiation-Protective AgentsBackground RadiationHead and Neck NeoplasmsRadiodermatitisCell SurvivalTime FactorsAntineoplastic Combined Chemotherapy ProtocolsRadiotherapy, High-EnergyBreast NeoplasmsOrgans at RiskUltraviolet RaysNeoplasm StagingDNA DamageCobalt RadioisotopesAntineoplastic Agents, PhytogenicRadiation EffectsProstatic NeoplasmsDrug Resistance, NeoplasmCarcinoma, Squamous CellRetrospective StudiesChemoradiotherapySurvival AnalysisRadiobiologyAdenocarcinomaFluorouracilTomography, X-Ray ComputedMice, NudeDisease-Free SurvivalChromatin Assembly and DisassemblyAntibiotics, AntineoplasticTumor Cells, CulturedX-RaysSurvival RateTumor BurdenLung NeoplasmsFollow-Up StudiesEtoposidePaclitaxelMastectomy, SegmentalDrug Delivery SystemsAcute Radiation SyndromeChemotherapy, AdjuvantRelative Biological EffectivenessGlioblastomaPrognosisCell ProliferationRadioactive Hazard ReleaseDacarbazineLinear Energy TransferFour-Dimensional Computed TomographyLymphatic IrradiationDrug CarriersActuarial AnalysisDNA RepairGliomaLeukemia, Radiation-InducedRadiation Hybrid MappingPhantoms, Imaging